Abstract
Spectral karyotyping (SKY) is a novel cytogenetic technique, which has been developed to unambiguously display and identify all 24 human chromosomes at one time without previous knowledge of any abnormalities involved. SKY can discern aberrations that fail to be easily detected by conventional banding techniques and by fluorescent in situ hybridization (FISH). Therefore SKY is highly accurate, highly sensitive, and highly prognostic. In this report the featurese and application of SKY in studies of leukemia are reviewed.
Similar content being viewed by others
References
Speicher MR, Gwyn Ballard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 1996;12:368–375.
Schock E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science. 1996;273:494–497.
Fan YS, Siu VM, Jung JH, et al. Sensitivity of multiple color spectral karyotyping in detecteding small interchromosomal rearrangements. Genet Test. 2000;4:9–14.
Schock E, Veldman T, Padilla-Nash H, et al. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet. 1997;101:255–262.
Tchinda J, Neumann TE, Volpert S, et al. Characterization of Chromosomal Rearrangements in Hematological Diseases Using Spectral Karyotyping. Diagn Mol Pathol. 2004;13:190–195.
Kakazu N, Taniwaki M, Horiike S, et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer. 1999;26:336–345.
Ye CJ, Lu W, Liu G, et al. The combination of SKY and specific loci detection with FISH or immunostaining. Cytogenet Cell Genet. 2001;93:195–202.
Nordgren A, Heyman M, Sahlen S, et al. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol. 2002;68:31–41.
Zhang FF, Murata-Collins JL, Gaytan P, et al. Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia. Genes Chromosomes Cancer. 2000;28:318–328.
Odero MD, Carlson KM, Calasanz MJ, et al. Further characterization of complex chromosomal rearrangements in myeloid malignancies: spectral karyotyping adds precision in defining abnormalities associated with poor prognosis. Leukemia. 2001;15:1133–1136.
Veldman T, Vignon C, Schrock E, et al. Hidden chromosome abnormalities in haematological malignancies detected by multi-color spectral karyotyping. Nat Genet. 1997;15:406–410.
Mrozek K, Tanner SM, Heinonen K, et al. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization. Genes Chromosomes Cancer. 2003;38:249–252.
Pelz AF, Weilepp G, Wieacker PF. Re-analysis of the cell line NALM-1 karyotype by GTG-banding, spectral karyotyping, and whole chromosome painting. Cancer Genet Cytogenet. 2005;156:59–61.
Chen IM, Whalen M, Bankhurst A, et al. A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization. Leuk Res. 2004;28:275–284.
Ohsaka A, Hisa T. Spectral karyotyping refined the identification of a der(Y)t(Y;1)(q11.1 or.2;q12) in the blast cells of a patient with atypical chronic myeloid leukemia. Acta Haematol. 2002;107:224–229.
Hilgenfeld E, Padilla-Nash H, McNeil N, et al. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukemia M2. Br J Haematol. 2001;113:305–317.
Mohr B, Bornhauser M, Thiede C, et al. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia. 2000;14:1031–1038.
Gitte BK, Eigil Kjeldsen, Acute Leukemia cytogenetics: an evaluation of combining G-band karyotyping with multicolor spectral karyotyping. Cancer Genetics and Cytogenetics. 2001;124:7–11.
Lu XY, Harris CP, Cooley L, et al. The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia. Leukemia 2002;16:2222–2227.
Mrozek K, Heinonen K, Theil KS, et al. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosomes Cancer. 2002;34:137–153.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Guo, B., Da, W. & Han, X. The application of spectral karyotyping in leukemia. Chin. J. Clin. Oncol. 3, 254–257 (2006). https://doi.org/10.1007/s11805-006-0051-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11805-006-0051-y